• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

核反应堆事故——使用碘化钾作为阻止甲状腺摄取放射性碘的阻断剂——综述

Nuclear reactor accidents--the use of KI as a blocking agent against radioiodine uptake in the thyroid--a review.

作者信息

Crocker D G

出版信息

Health Phys. 1984 Jun;46(6):1265-79. doi: 10.1097/00004032-198406000-00009.

DOI:10.1097/00004032-198406000-00009
PMID:6373674
Abstract

This paper is intended for those people who are responsible for the public health and safety in the event of a nuclear reactor accident. The possibilities and consequences of a radioiodine release are examined briefly. The possible side effects of stable iodine, the prognosis for radiation-induced thyroid disease, and the alternative protective measures are put into perspective and assessed for their individual risks and benefits. It is recommended that all appropriate counter-radiation measures be considered in the case of a reactor accident, and that the harmful side effects of the various actions be weighed carefully. Definitive guidelines as to when the use of KI is justified must be decided upon before implementing mass distribution.

摘要

本文面向那些在核反应堆事故发生时负责公众健康与安全的人员。简要探讨了放射性碘释放的可能性及后果。对稳定碘的可能副作用、辐射诱发甲状腺疾病的预后情况以及替代防护措施进行了综合考量,并评估了它们各自的风险与益处。建议在反应堆事故发生时考虑所有适当的反辐射措施,并仔细权衡各种行动的有害副作用。在实施大规模分发之前,必须确定使用碘化钾(KI)的合理时机的明确指导方针。

相似文献

1
Nuclear reactor accidents--the use of KI as a blocking agent against radioiodine uptake in the thyroid--a review.核反应堆事故——使用碘化钾作为阻止甲状腺摄取放射性碘的阻断剂——综述
Health Phys. 1984 Jun;46(6):1265-79. doi: 10.1097/00004032-198406000-00009.
2
Iodide prophylaxis in Poland after the Chernobyl reactor accident: benefits and risks.切尔诺贝利反应堆事故后波兰的碘预防措施:益处与风险。
Am J Med. 1993 May;94(5):524-532. doi: 10.1016/0002-9343(93)90089-8.
3
Reactor accidents. Public health strategies and their medical implications.反应堆事故。公共卫生策略及其医学影响。
JAMA. 1987 Aug 7;258(5):649-54. doi: 10.1001/jama.258.5.649.
4
The effects of iodine blocking following nuclear accidents on thyroid cancer, hypothyroidism, and benign thyroid nodules: design of a systematic review.核事故后碘阻断对甲状腺癌、甲状腺功能减退和甲状腺良性结节的影响:一项系统评价的设计
Syst Rev. 2015 Sep 24;4:126. doi: 10.1186/s13643-015-0106-3.
5
The use of iodine as a thyroidal blocking agent in the event of a reactor accident. Report of the Environmental Hazards Committee of the American Thyroid Association.反应堆事故时将碘用作甲状腺阻滞剂。美国甲状腺协会环境危害委员会报告。
JAMA. 1984 Aug 3;252(5):659-61.
6
The effects of iodine blocking on thyroid cancer, hypothyroidism and benign thyroid nodules following nuclear accidents: a systematic review.核事故后碘阻断对甲状腺癌、甲状腺功能减退和良性甲状腺结节的影响:一项系统评价
J Radiol Prot. 2016 Dec;36(4):R112-R130. doi: 10.1088/0952-4746/36/4/R112. Epub 2016 Sep 21.
7
Criteria for the administration of KI for thyroid blocking of radioiodine.用于放射性碘甲状腺阻断的碘化钾给药标准。
Health Phys. 1985 Feb;48(2):141-57. doi: 10.1097/00004032-198502000-00001.
8
Potassium iodide for thyroid blockade in a reactor accident: administrative policies that govern its use.反应堆事故中用于甲状腺阻滞的碘化钾:规范其使用的管理政策。
Thyroid. 1997 Apr;7(2):193-7. doi: 10.1089/thy.1997.7.193.
9
Thyroid dose estimation with potassium iodide (KI) administration in a nuclear emergency.核应急情况下服用碘化钾(KI)时的甲状腺剂量估算。
Radiat Prot Dosimetry. 2008;132(3):303-7. doi: 10.1093/rpd/ncn299. Epub 2008 Dec 3.
10
[Uses and risk of iodine prophylaxis in nuclear reactor accidents].
Internist (Berl). 1981 May;22(5):304-7.

引用本文的文献

1
Nuclear detonation, thyroid cancer and potassium iodide prophylaxis.核爆炸、甲状腺癌与碘化钾预防
Indian J Endocrinol Metab. 2011 Apr;15(2):96-8. doi: 10.4103/2230-8210.81937.
2
Evaluation of potassium iodide prophylaxis knowledge and nuclear emergency preparedness: New Jersey 2005.碘化钾预防知识与核应急准备情况评估:新泽西州,2005年
Am J Public Health. 2007 Apr;97 Suppl 1(Suppl 1):S100-2. doi: 10.2105/AJPH.2006.094573. Epub 2007 Apr 5.